IIT Kanpur and Conlis Global Signs MoU for Indigenous Bone Regeneration Technology

IIT Kanpur has entered into a Memorandum of Understanding with Conlis Global Inc to license a groundbreaking technology aimed at enhancing bone repair and regeneration. Get details here 

The Indian Institute of Technology (IIT) Kanpur has signed a Memorandum of Understanding (MoU) with Canadian biotechnology firm Conlis Global Inc. This collaboration is set to license a pioneering technology developed to advance bone healing and regeneration. Conlis Global Inc specialises in transitioning products from research and development stages to the marketplace.

The MoU was signed by Prof Tarun Gupta, Dean of Resources and Development IIT Kanpur, and Dr Sumrita Bhat, CEO, Conlis Global Inc at IIT Kanpur in the presence of Prof S Ganesh, Director, IIT Kanpur; Prof Ankush Sharma, Professor In-charge, Start-up Incubation and Innovation Centre (SIIC), IIT Kanpur; Prof Ashok Kumar, Department of Biological Sciences & Bioengineering, IIT Kanpur; and Dr Raman Koul, Chief Technology Officer, Conlis Global Inc.

Prof. S. Ganesh, Director, IIT Kanpur said, "The licensing of this novel technology developed in-house that promotes bone healing and regeneration to Conlis Global is yet another significant milestone in the R&D endeavour of the Institute."

Nano Hydroxyapatite-Based Porous Polymer Composite Scaffolds 

The technology, "Nano Hydroxyapatite-Based Porous Polymer Composite Scaffolds for Bioactive Molecule Delivery in Musculoskeletal Regeneration" has been developed by Prof. Ashok Kumar and his team from the Department of Biological Sciences & Bioengineering at IIT Kanpur.

The innovative Nano Hydroxyapatite-based Porous Composite Scaffolds, designed for bone regeneration, are biodegradable and possess both osteoinductive (facilitating the bone healing process) and osteopromotive (acting as a substrate for new bone growth) properties. These scaffolds are highly compatible with biological tissues, ensuring effective interaction with osteoblast cells (the cells that play a crucial role in the mineralization of bone during formation and remodeling). 

The invention aims to address the limitations and complications, such as infection and immune issues, associated with current treatments. It offers a novel method for delivering bone-active molecules, antibiotics, or other drugs to treat bone pathologies, repair irregular bone defects, and support dental applications.

Read More

• IIT Kanpur-mentored Indian Institute of Skills Inaugurated by PM Narendra Modi Virtually
• IIT Kanpur, SIDBI, and SIIC Forge 25-Year Strategic Plan to Elevate UP as Startup Hub